LAUSR

Micro‐Abstract In an evaluation of the prognostic role of sex on colorectal cancer (CRC)‐specific outcomes, we reviewed all patients with resected stage I to III colorectal cancer referred to cancer centers in a large, representative Canadian province. Men had worse overall and recurrence‐free survival compared to women; however, CRC‐specific survival and time to recurrence did not differ significantly between men and women. This suggests that the trajectory of CRC is similar irrespective of sex when noncancer causes of death are excluded. Background Women have been shown to experience longer overall survival after colorectal cancer (CRC) diagnosis than men even after adjusting for disease stage and management. However, the etiology of this observation is not well understood, and the impact of non‐CRC health conditions on survival has not been described. We aimed to evaluate the prognostic role of sex on CRC‐specific outcomes. Patients and Methods All patients who underwent primary resection of stage I to III CRC from 2001 to 2005, and who were referred to cancer centers in a large, representative Canadian province were reviewed. Baseline patient characteristics, including common comorbidities, were compared between men and women. Multivariable analysis was used to evaluate the associations between sex and survival outcomes. Results We identified 1837 patients. Median age was 69 (interquartile range 60‐76) years, and there were 867 women (47%) and 970 men (53%). Men were more likely to report ischemic heart disease, diabetes, dyslipidemia, and obesity (all P < .001). On multivariable analysis, men had worse overall and recurrence‐free survival compared to women (hazard ratio [HR] = 1.38, 95% confidence interval [CI] 1.15‐1.64; and HR = 1.40, 95% CI, 1.18‐1.67, respectively). However, CRC‐specific outcomes, including CRC‐specific survival and time to recurrence, did not differ significantly between men and women (HR = 1.15, 95% CI, 0.91‐1.45; and HR = 1.12, 95% CI, 0.90‐1.40, respectively). Conclusion Women diagnosed with early stage CRC lived longer and had better general health than men. When noncancer causes of death were excluded, however, the trajectory of CRC appeared similar irrespective of sex. Early identification and better management of comorbidities may narrow the survival gap between men and women.